Eko Low Ejection Fraction Tool (ELEFT) vs Rhythm360

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by RhythmScience

AI Verdict

Tool A (ELEFT) is an AI-powered screening tool designed for early detection of low ejection fraction during routine physical exams using digital stethoscopes. Tool B (Rhythm360) is a broader AI platform that aggregates and analyzes cardiac monitoring data from various devices to provide insights for managing conditions like heart failure, hypertension, and arrhythmias, and to reduce alert fatigue. While both leverage AI in cardiology and address aspects of heart failure, ELEFT focuses on point-of-care screening, whereas Rhythm360 provides a comprehensive solution for ongoing remote patient monitoring and data management.

Choose Eko Low Ejection Fraction Tool (ELEFT) if…

Choose Eko Low Ejection Fraction Tool (ELEFT) if your primary goal is to quickly and non-invasively screen for low ejection fraction during routine physical exams. This tool is ideal for clinicians, including those in primary care, who need an FDA-cleared AI solution integrated with a digital stethoscope to aid in the early identification of heart failure risk at the point of care.

View Eko Low Ejection Fraction Tool (ELEFT) →

Choose Rhythm360 if…

Choose Rhythm360 if you require a comprehensive, AI-powered platform to unify and manage cardiac monitoring data from diverse devices across your patient population. This solution is best suited for cardiology practices aiming to reduce alert fatigue, gain actionable insights for complex conditions like heart failure and arrhythmias, and streamline administrative tasks like EHR integration and automated billing for remote patient monitoring.

View Rhythm360 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Low Ejection Fraction Tool (ELEFT) Rhythm360
Pricing Unknown Flexible pricing model that scales with clinic size and platform usage.
Deployment Unknown Cloud-based SaaS platform
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Unknown
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Rhythm360

Rhythm360 explicitly prioritizes user experience by offering an all-in-one web application and mobile app designed to unify diverse cardiac data, reduce alert fatigue, and streamline administrative tasks for cardiologists. While ELEFT offers quick, non-invasive detection during a routine exam, Rhythm360's broader scope and focus on simplifying complex workflows across multiple devices and administrative functions suggest a more comprehensive usability advantage for its target users.

Clinical Value

Rhythm360

While ELEFT provides significant clinical value through FDA-cleared, early, non-invasive detection of low ejection fraction, Rhythm360 demonstrates a broader and more direct measurable clinical impact across multiple cardiac conditions. Its AI-powered platform has shown an 80% faster response time for critical alerts and a 74% reduction in hospitalizations for heart failure patients through optimized Guideline-Directed Medical Therapy, directly improving patient outcomes and safety.

Pricing & Value

Rhythm360

While both tools require contacting sales for specific pricing, Rhythm360 explicitly highlights a flexible, scalable SaaS model and demonstrates clear financial value through automated CPT code documentation and billing, leading to reported revenue increases of up to 300%. ELEFT's pricing is less transparent, though CMS has established a payment rate for its platform, indicating a path to reimbursement.

Enterprise Readiness

Rhythm360

Rhythm360 demonstrates superior enterprise readiness due to its comprehensive vendor-neutral data aggregation from all major cardiac device OEMs and robust bi-directional EHR integration with leading systems. This extensive interoperability, combined with automated billing and compliance features, positions it as a more adaptable and integrated solution for large healthcare enterprises.

Innovation

Rhythm360

While ELEFT innovates by embedding AI-powered early heart failure detection into a routine stethoscope exam, Rhythm360 offers a broader and more complex suite of innovations. Its vendor-neutral data aggregation from all major OEMs, AI-driven alert triage that significantly reduces response times and fatigue, predictive algorithms for GDMT optimization, and automated billing demonstrate a more comprehensive and impactful approach to modern cardiac care management.

Support & Docs

Rhythm360

Rhythm360 offers a higher level of direct support through its optional 24/7/365 oversight by certified cardiac technicians, providing continuous expert monitoring. While Eko Health provides standard documentation and a help center, Rhythm360's integrated human oversight alongside its knowledge base represents a more robust and proactive support model.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Low Ejection Fraction Tool (ELEFT) Rhythm360
Tool Name Eko Low Ejection Fraction Tool (ELEFT) Rhythm360
Company Eko Health RhythmScience
Primary Function FDA-cleared AI algorithm that integrates with Eko digital stethoscopes to aid clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams. AI-powered integrated platform that unifies cardiac monitoring data from various devices, providing actionable insights for hypertension, heart failure, and rhythm management, and reducing alert fatigue.
Key Integrations Eko digital stethoscopes. Vendor-neutral data aggregation (all major OEMs: Medtronic, Boston Scientific, Abbott, Biotronik); Bi-directional EHR integration (Epic, Cerner, Athenahealth, eClinicalWorks, GreenwayHealth, GE Centricity).
Supported Specialties Cardiology, Family Medicine, Internal Medicine Cardiology
Unique Feature AI-powered low ejection fraction detection; analyzes ECG and heart sound recordings; provides results in approximately 15 seconds. Vendor-neutral data aggregation; AI-driven alert triage (80% faster response times); Automated CPT code documentation and billing; Optional 24/7/365 oversight by certified cardiac technicians (CCTs).

Videos

Demos, reviews, and walkthroughs featuring Eko Low Ejection Fraction Tool (ELEFT) and Rhythm360.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Eko Low Ejection Fraction Tool (ELEFT) integrates with Eko digital stethoscopes, providing AI-powered low ejection fraction detection results in approximately 15 seconds during routine physical exams. Rhythm360, conversely, is an integrated platform that unifies cardiac monitoring data from various devices and offers bi-directional EHR integration with major systems like Epic and Cerner, streamlining data review and automated documentation.
ELEFT is designed for the early, non-invasive detection of low ejection fraction, a key indicator of heart failure, during routine physical exams, making it suitable for cardiology, family medicine, and internal medicine. Rhythm360 focuses on comprehensive cardiac monitoring data unification, providing actionable insights for hypertension, heart failure, and rhythm management, primarily for cardiology specialists.
ELEFT provides a single, rapid AI analysis for low ejection fraction during an exam, offering immediate screening insights. Rhythm360 utilizes AI-driven alert triage to process critical alerts 80% faster, reducing alert fatigue by filtering non-actionable notifications and prioritizing significant events from various cardiac monitoring devices.
ELEFT integrates with Eko digital stethoscopes, with cloud-based data processing and storage, but direct EHR integration depth is not explicitly detailed beyond this. Rhythm360 offers deep, bi-directional EHR integration with major systems like Epic, Cerner, and Athenahealth, facilitating seamless data flow, automated CPT code documentation, and billing.
The provided information for ELEFT does not specify the level of ongoing support or clinical oversight. Rhythm360 offers optional 24/7/365 oversight by certified cardiac technicians (CCTs), which can further support timely responses to critical events.
ELEFT provides rapid results in approximately 15 seconds during a routine physical exam, offering immediate insights for early detection of low ejection fraction. Rhythm360 boasts up to 80% faster response times for critical alerts, reduced alert fatigue, and automated CPT code documentation and billing, suggesting rapid operational and financial efficiency improvements.
ELEFT is part of Eko's SENSORAu2122 platform, which is described as an enterprise solution, implying scalability for multi-site deployment. Rhythm360 is a cloud-based SaaS platform with a flexible pricing model that scales with clinic size and platform usage, designed for comprehensive cardiology practices and capable of unifying data across multi-site operations.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.